Pharmacotherapy, as a means of treating drug addiction in
combination with other treatment modalities, has received too
little attention from the research community, the pharmaceutical
industry, public health officials, and the federal government.
Medications to combat drug addiction could have an enormous impact
on the medical consequences and socioeconomic problems associated
with drug abuse, both for drug-dependent individuals and for
American society as a whole. This book examines the current
environment for and obstacles to the development of anti-addiction
medications, specifically those for treating opiate and cocaine
addictions, and proposes incentives for the pharmaceutical industry
that would help overcome those obstacles and accelerate the
development of anti-addiction medications.
National Academies Press
|Country of origin:
Institute Of Committee to Study Medication Development and Research at the National Institute on Drug Abuse
• Carolyn E Fulco Catharyn T Liverman and Laurence E Earley
And Laurence Carolyn E Fulco Catharyn T Liverman
||Electronic book text
Clinical & internal medicine >
Neurology & clinical neurophysiology
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!